Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | MVD | P53602 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3029332 | 0.79 | CYP3A4 (0.46) | TDP1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7132609 | 0.77 | CHRM2 (0.39) | TDP1CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1642999 | 0.75 | LPAR3 (0.46) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL11178967 | 0.75 | CHRNB2 (0.38) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL7873122 | 0.75 | CHRM2 (0.38) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL10937857 | 0.75 | CHRM2 (0.38) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL7456978 | 0.75 | CHRM2 (0.38) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL30946964 | 0.74 | TP53 (0.56) | TP53TDP1ALDH1A1 | |
| SCHEMBL15150921 | 0.73 | CHRM2 (0.37) | CHRM2CHRM4CHRM5CHRM1CHRNB2 | |
| SCHEMBL15263479 | 0.73 | CHRM2 (0.37) | CHRM2CHRM4CHRM5CHRM1CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170333575-A1 | POLYMER AND CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING INCLUDING THE POLYMER | CANON KABUSHIKI KAISHA (JP) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170333575-A1 | POLYMER AND CONTRAST AGENT FOR PHOTOACOUSTIC IMAGING INCLUDING THE POLYMER | PHOSPHO1, PCTP, PAICS | TP53 1311/4885TDP1 3612/4885CHRM2 4035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.